Latest Articles

Publication Date
Bliss IVF Highlights Fertility Success Through Twin Birth in Advanced Endometriosis Case - MyNation

Bliss IVF Highlights Fertility Success Through Twin Birth in Advanced Endometriosis Case MyNation

Published: June 18, 2026, 3:47 a.m.
This disease is affecting one in 10 women - what Bradford district is doing about it - Telegraph and Argus

This disease is affecting one in 10 women - what Bradford district is doing about it Telegraph and Argus

Published: June 18, 2026, midnight
Bliss IVF Highlights Fertility Success Through Twin Birth in Advanced Endometriosis Case - First India

Bliss IVF Highlights Fertility Success Through Twin Birth in Advanced Endometriosis Case First India

Published: June 17, 2026, 1:57 p.m.
Bliss IVF Highlights Fertility Success Through Twin Birth In Advanced Endometriosis Case - outlookbusiness.com

Bliss IVF Highlights Fertility Success Through Twin Birth In Advanced Endometriosis Case outlookbusiness.com

Published: June 17, 2026, 1:44 p.m.
Bliss IVF Highlights Fertility Success Through Twin Birth in Advanced Endometriosis Case - NewsX

Bliss IVF Highlights Fertility Success Through Twin Birth in Advanced Endometriosis Case NewsX

Published: June 17, 2026, 1:06 p.m.
Leerink’s AI Pipeline Focus and Jones AI Day Spotlight Might Change The Case For Investing In Absci (ABSI) - simplywall.st

Leerink’s AI Pipeline Focus and Jones AI Day Spotlight Might Change The Case For Investing In Absci (ABSI) simplywall.st

Published: June 17, 2026, 9:33 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - beQuoted

Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat beQuoted

Published: June 17, 2026, 9 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - The Manila Times

Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat The Manila Times

Published: June 17, 2026, 8:29 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - Yahoo Finance Singapore

Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat Yahoo Finance Singapore

Published: June 17, 2026, 8:05 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - Dagens industri

Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat Dagens industri

Published: June 17, 2026, 7:01 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!